Biotech Compounds
Tesa-Ipa
Research Compound

Tesa-Ipa

Tesa-Ipa is a two-component laboratory blend supplied in a single vial containing Tesamorelin 12mg and Ipamorelin 6mg. Tesamorelin is a synthetic analog of human GHRH(1-44) bearing an N-terminal hexenoyl modification studied for the resistance it confers to enzymatic cleavage; Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the GHS-R1a (ghrelin) receptor. Because the two peptides bind unrelated receptor families, the blend is supplied as a paired reference material for in vitro receptor-binding and receptor-selectivity panels, cAMP and calcium-flux assays in transfected cell lines, and chromatographic separation, identity, and purity work by HPLC and LC-MS/MS. For research and laboratory use only; not for human or animal consumption.

Select Size
18mg
SKU: TI18
Batch: 202609-01-TI
$161.99
Ships today if ordered by 4PM EST
Est. Arrival: 09/16/2026
Volume Discounts
Qty: 1 - 4$161.99 each
Qty: 5 - 9$145.79 each(save $16.20)
Qty: 10+$129.59 each(save $32.40)
Quantity:
1
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.
99%+ Purity
COA Included
Fast Shipping
USA Based
Categories:
HormonalTherapeutic
Tags:
Tesa-IpaTesamorelinIpamorelinpeptide blendGHRH analogGHRH receptorGHRH(1-44)hexenoyl modificationGHS-R1a agonistghrelin receptorpentapeptidereceptor selectivity panelreceptor binding assayreference standardresearch peptide

Product Details

Tesa-Ipa is a laboratory blend of two structurally distinct synthetic peptides, Tesamorelin and Ipamorelin, supplied together in a single vial for comparative in vitro work across two separate receptor targets.


Tesamorelin is a synthetic analog of human GHRH(1-44) modified with an N-terminal hexenoyl group. That modification is the subject of serum-stability and degradation assays, where it is studied for the resistance it confers to enzymatic cleavage relative to the unmodified sequence. In receptor pharmacology Tesamorelin is characterized as an agonist at the GHRH receptor, a class B G-protein-coupled receptor, and is used in vitro as a ligand for GHRH-receptor binding affinity measurements and cAMP accumulation assays in transfected cell lines.


Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the ghrelin receptor GHS-R1a. In comparative in vitro binding panels it is noted for selectivity toward GHS-R1a over other pituitary-expressed receptor targets, which makes it a useful reference ligand when profiling receptor cross-reactivity and assay specificity.


Because the two peptides engage unrelated receptor families, the blend is used in laboratory settings as a paired reference material for receptor-selectivity panels, radioligand and fluorescence-polarization binding assays, calcium-flux and cAMP readouts, and reversed-phase HPLC or LC-MS/MS separation, identity confirmation, and purity determination of the two components.


Tesamorelin: 12mg

Ipamorelin: 6mg


Disclaimer: Tesa-Ipa is supplied strictly for research and laboratory use only. This product is not a drug, dietary supplement, or medical device. It is not intended for human or animal consumption, and not for therapeutic, diagnostic, or clinical application. It has not been evaluated by the FDA, and no statement here should be read as a claim to diagnose, treat, cure, or prevent any condition. All handling should be performed by qualified researchers in accordance with applicable laboratory safety protocols and institutional guidelines.

Frequently Asked Questions About Tesa-Ipa

Answers summarize published research and are provided for laboratory research purposes only.

Tesa-Ipa is a two component laboratory blend supplied in a single vial containing Tesamorelin 12mg and Ipamorelin 6mg. Tesamorelin is a synthetic analog of human GHRH(1-44) with an N-terminal hexenoyl modification, and Ipamorelin is a synthetic pentapeptide characterized as a selective GHS-R1a agonist. Because the two peptides act on unrelated receptor families, research studies have used the Tesa-Ipa blend as a paired reference material for receptor selectivity panels and chromatographic identity and purity work.
In receptor pharmacology research, the Tesamorelin in Tesa-Ipa has been characterized as an agonist at the GHRH receptor, a class B G-protein coupled receptor, and researchers have used it in cAMP accumulation assays in transfected cell lines. The Ipamorelin in Tesa-Ipa has been characterized in research studies as a selective agonist at the ghrelin receptor GHS-R1a. In vitro binding panels have noted its selectivity for GHS-R1a over other pituitary expressed receptors.
The primary research use of Tesa-Ipa is comparative in vitro receptor work. Researchers have used the blend as a paired ligand set in radioligand and fluorescence polarization binding assays, calcium flux readouts, and cAMP assays, where one component engages the GHRH receptor and the other engages GHS-R1a. Having both peptides in one vial allows a laboratory to profile receptor cross reactivity and assay specificity using two structurally distinct compounds from the same lot.
A second research area for Tesa-Ipa is analytical chemistry. Because Tesamorelin is a 44 amino acid peptide and Ipamorelin is a pentapeptide, the blend is used for reversed phase HPLC and LC-MS/MS method development, where the two components separate cleanly and serve as identity and purity markers. The hexenoyl modification on Tesamorelin is also studied in serum stability assays, where researchers have reported that it confers resistance to enzymatic cleavage compared with the unmodified GHRH sequence.
Evidence for the Tesa-Ipa components comes from separate literatures. Tesamorelin has been studied in cell based receptor assays, animal models, and human clinical trials as a GHRH analog. Ipamorelin has been characterized in vitro and in animal models as a selective growth hormone secretagogue. The Tesa-Ipa blend itself is a laboratory reference material and has not been the subject of its own clinical trials. It is supplied by Biotech Compounds for in vitro and analytical research only.
Tesamorelin alone is a single peptide vial containing only the GHRH(1-44) analog. Tesa-Ipa adds Ipamorelin 6mg to Tesamorelin 12mg in one vial. Research studies have characterized Tesamorelin as a GHRH receptor agonist and Ipamorelin as a GHS-R1a agonist, so Tesa-Ipa gives a laboratory two receptor probes from unrelated families in one preparation. Researchers who need a single ligand for a GHRH receptor assay choose Tesamorelin, while those running selectivity panels choose Tesa-Ipa.
Both blends pair a GHRH receptor ligand with the GHS-R1a agonist Ipamorelin, but the GHRH component differs. Tesa-Ipa uses Tesamorelin, the full 44 amino acid GHRH sequence with an N-terminal hexenoyl group that research studies have reported resists aminopeptidase cleavage. The Ipamorelin and CJC-1295 no DAC blend uses a modified 29 amino acid GHRH fragment instead. Researchers comparing full length and truncated GHRH analogs against the same ghrelin receptor ligand can run the two blends side by side.
Tesa-Ipa is supplied as a lyophilized powder containing both peptides. To reconstitute, Bacteriostatic Water or sterile water is added slowly down the inside wall of the vial so it flows onto the Tesa-Ipa powder without splashing. The vial is then gently swirled or rolled until both components dissolve and the solution is clear. The vial should never be shaken, since agitation can damage the longer Tesamorelin chain in particular.
Lyophilized Tesa-Ipa should be stored cold, ideally at minus 20 C, in a sealed vial protected from light and moisture. After reconstitution, Tesa-Ipa solution should be refrigerated at 2 to 8 C, protected from light, and used within a short window. Freeze thaw cycles should be avoided. Serum stability research has reported that the hexenoyl modified Tesamorelin component resists enzymatic breakdown better than native GHRH, but the reconstituted blend should still be treated as perishable.
Yes. Tesa-Ipa from Biotech Compounds is listed at 99 percent or higher purity and each lot is tested by an independent laboratory. The Certificate of Analysis for Tesa-Ipa is posted on the product page and reports identity and purity for both the Tesamorelin and Ipamorelin components of that batch. Researchers should match the lot number on the Tesa-Ipa vial to the posted COA before starting work.
No. Tesa-Ipa from Biotech Compounds is sold strictly as a research material for laboratory research by qualified researchers and research organizations. Purchasers must be 21 years of age or older. Tesa-Ipa sold here is not a drug, a dietary supplement, or a medical device, has not been evaluated by the FDA, and is not for human or animal consumption. It is intended only for in vitro and analytical laboratory use.
You May Also Like

Related Products

AOD-9604

AOD-9604

$43.99 / from
Aviptadil

Aviptadil

$215.99 / from
Cagri-GLP1S

Cagri-GLP1S

$64.99 / from
Cagri-GLP3R

Cagri-GLP3R

$118.99 / from